South Texas Accelerated Research Therapeutics | START Mountain Region
Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
The purpose of this study is to find out whether the study drug, LY4170156, is safe, tolerable and effective in participants with advanced solid tumors. The study is conducted in two parts - phase Ia (dose-escalation, dose-optimization) and phase Ib (dose-expansion). The study will last up to approximately 4 years.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Have one of the following solid tumor cancers:
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
220 participants in 3 patient groups
Loading...
Central trial contact
There may be multiple sites in this clinical trial. 1-877-CTLILLY (1-877-285-4559) or
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal